Psilocybin-assisted Psychotherapy for Fear of Cancer Recurrence in Early-Stage Breast Cancer
Official title: Psilocybin-assisted Psychotherapy to Treat Fear of Cancer Recurrence in Early- Stage Breast Cancer
Funded at New York University School of Medicine · NIH-11344227 · Data updated 2026-11-12
A study will test whether a one-time psilocybin-assisted psychotherapy session helps reduce fear of cancer returning in women with early-stage breast cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 8, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $693,638 |
| NIH project number | 1R01CA312541-01 |
| Project ID | NIH-11344227 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with early-stage breast cancer who have significant fear of recurrence and are eligible for psilocybin-assisted therapy under study protocols.
✕Less likely to help
Individuals with contraindications to psilocybin or psychotherapy, or those not seeking this treatment approach, may not benefit.
What this research studies
If you are a woman with early-stage breast cancer and experiences fear that the cancer could come back, this trial would explore whether a guided psychotherapy session with a psilocybin-assisted dose could ease that worry. Participants would engage in psychotherapy alongside a controlled psilocybin experience under medical supervision, aiming for lasting reductions in anxiety, depression, and existential distress. The goal is to see if this approach provides meaningful and durable relief where current options are limited. The study builds on prior findings in cancer patients and seeks to confirm effects in a homogenous early-stage breast cancer group.
Why it matters
Potential benefit: If successful, participants may experience reduced fear of recurrence and improved quality of life.
How similar studies have gone: Earlier pilot trials in cancer patients suggest rapid and durable improvements in anxiety and existential distress with psilocybin-assisted therapy, but robust RCT data in early-stage breast cancer are needed.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Ross, Stephen — New York University School of Medicine
- Study coordinator: Ross, Stephen
Related research
Other NIH-funded projects on the same topics.
-
FoRtitude: an online program to ease fear of cancer recurrence for breast cancer survivors
A woman who has finished breast cancer treatment uses an online program to learn easy CBT-based steps to feel less worried about cancer coming back.
-
FoRtitude: An eHealth program to help breast cancer survivors manage fear of recurrence
This program offers breast cancer survivors an online tool to help them cope with the worry that their cancer might come back.
-
Impact of fear of cancer recurrence on health behaviors in breast cancer survivors and their partners
This study looks at how the fear of cancer coming back impacts the health habits of breast cancer survivors and their partners, focusing on things like taking medications, staying active, and getting good sleep, to help understand how these feelings and behaviors affect each other over time.
-
Helping breast cancer survivors manage their fear of cancer returning
This study is testing a helpful online program called FoRtitude, designed to support breast cancer survivors in managing their fear of the cancer coming back, using friendly tools and strategies over four weeks.
-
Helping breast cancer survivors cope with fear of cancer recurrence
This study is looking at how Acceptance and Commitment Therapy can help breast cancer survivors who are really worried about their cancer coming back, so they can feel better and live more fully.
-
Gene expression marks high risk for very late breast cancer return
A patient-focused study aims to find gene patterns that identify women with early breast cancer who are most likely to have cancer come back more than a decade later.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.